Project: Development of an optimised pancreatic cell tool kit to enable accelerated diabetes drug discovery

Acronym	PAN-KIT (Reference Number: 12988)
Duration	01/04/2019 - 02/10/2021
Project Topic	We will develop pancreatic beta cell models for type 2 diabetes research from human induced pluripotent stem cells (hiPSCs), improving their maturity and function. Complementary CRISPR gene-edited disease models will also be generated. 3D cell culture systems will then be developed using automation compatible 96- or 384-multiwell plate formats for high throughput screening and downstream drug evaluation. Market readiness of this platform will be evaluated by an industry beta testers.
Network	Eurostars 2
Call	Eurostars Cut–off 10

Project partner

Number	Name	Role	Country
1	DefiniGEN Ltd	Coordinator	United Kingdom
2	InSphero AG	Partner	Switzerland